tldrdailynews.com logo

"Uncovering the Impact: Promising Advances and Bold Predictions for Long COVID"

1 min read
Source: Medscape
"Uncovering the Impact: Promising Advances and Bold Predictions for Long COVID"
Photo: Medscape
TL;DR

Researchers are hopeful for progress in treating long COVID in 2024, with predictions including a better understanding of different long COVID phenotypes, the potential use of monoclonal antibodies to target viral persistence, the effectiveness of Paxlovid for long COVID treatment, the use of anti-inflammatories like metformin, and the potential role of serotonin levels and selective serotonin reuptake inhibitors (SSRIs) in alleviating long COVID symptoms.

Topics:healthhealth-medicine#health-medicine#long-covid#monoclonal-antibodies#research#serotonin-levels#treatments
Share this article
  1. Five Bold Predictions for Long COVID in 2024  Medscape
  2. Long COVID patients enduring symptoms and looking for answers  Scripps News
  3. A promising turn in the quest to treat long Covid  Bangkok Post
  4. New long COVID study uncovers high inflammation in patients as Senate calls for more research on 'crisis'  ABC News
  5. Impacts of lingering illness symptoms  13News Now

Want the full story? Read the original reporting

Read on Medscape